{% extends "layout.html" %}
  
{% block title %}Human Practices{% endblock %}
{% block lead %}Describe how and why you chose your iGEM project.{% endblock %}

{% block page_content %}

<!DOCTYPE html>
<html data-bs-theme="light" lang="en">
    <link href="{{ url_for('static', filename = '../../../../static/css/human-practices.css')}}" rel="stylesheet">
    <header>
        <div class="page-header" id="human-practices-header"></div>
    </header>
    <body>
        <div class="layout" style="overflow-x: hidden; overflow-y:hidden;">
            <!-- Start actual content of the page -->
             <p></p>
            <!-- Introduction -->
            <div class="contents outline">
                <div></div>
                <div class="container container-custom">
                
                  <div class="row mb-5 gx-0" id="introduction">
                    <div class="col-1 d-flex justify-content-center">
                    <div class="line-description" style="height:100%;"></div>
                    </div>
                    <div class="col-10">
                    <div class="row gx-5">
            
                        <div class="toc-section">
                        <h2>Introduction </h2>
                        <br>
                            <p align="justify">
                            <font color="#F6B227"><b>Human Practices</font></b> is an essential part of any iGEM project. It challenges engineers to make useful projects that <font color="#F6B227"><b>contribute to society</font></b>.  Synthetic biology can bring innovative approaches to solve some major societal problems, however it can also <font color="#F6B227"><b>raise many questions</font></b>. This is where Human Practices comes in to make the teams more aware of the <font color="#F6B227"><b>positive as well as the negative impact</font></b> of their project. Our objective is to fully <font color="#F6B227"><b>integrate</font></b> all stakeholders involved into our project to end up with a therapy that will truly be a great benefit to as many people as possible. 
                            </p>
                            <h4>Human Practices Page </h4>
                            <p align="justify">
                            On our Human Practices page you will find the work that we did for both <font color="#F6B227"><b>Silver Human Practices</font></b> and <font color="#F6B227"><b>Integrated Human practices</font></b>. The page will show you how we identified our stakeholders, considered their values, and implemented their needs into our project.  
                            <p align="justify">
                            On the <font color="#F6B227"><b>interactive timeline</font></b>, you will see that we have met many people from different backgrounds and discussed our project with them at all stages. We used the <font color="#F6B227"><b>Gibbs reflective cycle</font></b> numerous times after the conversations with stakeholders to find out which direction we needed to go in with the project. More about this can be read on the interactive timeline. 
                            </p>
                            <h4>Implementation Page </h4> 
                            <p align="justify">
                            On our implementation page, you will read more about how we intend <font color="#F6B227"><b>to bring cELPro into the world</font></b> in the future. On this page, you can find the information about the improvements we still intend to make on our design, the market research we did, our businessplan, and how we intend to eventually make cELPro available to patients.  
                            </p>
                        </div>
                    </div>
                    </div>
                </div>
            
                <!-- Silver Human Practices -->
                <div class="row mb-5 gx-0" id="inflammatory bowel disease">
                    <div class="col-1 d-flex justify-content-center">
                    <div class="line-description" style="height:100%;"></div>
                    </div>
                    <div class="col-10">
                    <div class="row gx-5">
            
                        <div class="col-12 mb-2">
                        <h2>Silver Human Practices </h2>
                            <p align="justify">
                                In this section of the Human Practices page, the <font color="#F6B227"><b>stakeholders</font></b> that can give relevent feedback on our project, cELPro, are <font color="#F6B227"><b>identified</font></b>. Moreover, we <font color="#F6B227"><b>analyzed their interest</font></b> in the folowing values: <font color="#F6B227"><b>safety and non-maleficence, public health, beneficence, justice, autonomy, profitability, innovation, and privacy</font></b>. <font color="#F6B227"><b>Click</font></b> on the menu's below to read more about this. 
                            </p>
                        </div>
                    </div>
                    </div>
                </div>
            
                <!-- Dropdownmenus -->
                <div class="row mb-5 gx-0" id="background" style="position:relative">
                    <div id="background-reference"></div>
                    <div class="col-1 d-flex justify-content-center">
                    <div class="line-description" style="height:100%;"></div>
                    </div>
                    <div class="col-10">
                    <div class="row gx-5">
            
                        <div class="col-12 mb-2">
                            <button class="greendropdown">
                                <h5>Stakeholder identification</h5>
                                <div class="arrow-circle-lightgreen"></div>
                            </button>
                            <div class="panelblue">
                                <div style="padding:1.25em 0.5em;">
                                    <p align="justify">
                                        As stated by the iGEM community: “Human Practices matters at every stage of your project”. With this thought in mind, the TU Eindhoven 2023 got inspired by the “syn-PNOIA Cycle” from the Patras Medicine 2022 team. This team from last year divided the iGEM journey into six chronological steps. A small adaptation of the “syn-PNOIA cycle” can be seen below.
                                    </p>
                                    
                                    <div style="text-align:center;">
                                        <img src="https://static.igem.wiki/teams/4905/wiki/booooooooiiii.svg" class="enlarge-image" style="width:300px;">
                                    </div>
                                    <p align="justify">
                                        The iGEM journey starts by defining and understanding the problem the team wants to tackle and ends with the proposed implementation into the real world. At every step, stakeholders are of great interest. Involvement with stakeholders helps to develop a project that is good and responsible for the world. However, not every stakeholder is equally useful at each step of the cycle. That is why the Human Practices team did a stakeholder identification to identify which stakeholders are of interest at which step. The results of the brainstorm session can be seen below. 
                                    </p>
                                    
                                    <div style="text-align:center;">
                                        <img src="https://static.igem.wiki/teams/4905/wiki/hp/stakeholder-identification-pt-2.svg" class="enlarge-image" style="width:450px; padding-bottom: 8px;">
                                    </div>
                                    <p align="justify">
                                        After we discussed what stakeholders are of importance for our project at all five steps, we grouped all stakeholders into the six following categories: 
                                        <ul>
                                            <li>Science and research institutes</li>
                                            <li>Safety and ethics  </li>
                                            <li>Health care and hospitals  </li>
                                            <li>Laws and regulations </li>
                                            <li>Business and industry </li>
                                            <li>Public organizations and communities </li>
                                        </ul>
                                    </p>
                                </div>
                            </div>
                            
                            <!-- START dropdown-->
                            <button class="lightgreendropdown">
                                <h5>Value-sensitive analysis</h5>
                                <div class="arrow-circle-green"></div>
                            </button>
                            <div class="panelblue">
                                <div style="padding:1.25em 0.5em;">
                                    <!-- Add your text between the <p> -->
                                    <p align="justify">
                                        We have to take into account that the stakeholders from the different categories described in the stakeholder identification section will have different interests. Furthermore, it is relevant for us to know what the focus is of the stakeholder, since in the end, they all need to be satisfied if we want to develop a successful product. To make the best design, the first step is to find out what the most important values are to our stakeholders.
                                    </p>
                                    <p align="justify">
                                        We want to take a consumer-driven product design approach which has been proven to better fulfill the needs of the user than other methods<sup>[1]</sup>. This means that we will use <font color="#F6B227"><b>value-sensitive design (VSD)</b></font> to keep in mind and prioritize the values of our stakeholders, while also keeping track of the technological limitations of the design. This type of analysis has also been used by many other iGEM teams, such as those from TU Delft 2021 and TU Eindhoven 2022. However, we have given it our own spin.
                                    </p>
                                    <p align="justify">
                                        VSD combines conceptual, empirical, and technical investigations<sup>[2]</sup>. This means that there needs to be a combination of stakeholder interviews, literature research, and a consideration of the technical limits of the product to find the best design eventually. This is not a step-by-step process but needs to be done over multiple iterative cycles to design a successful product. The process was perfectly described by Graubom et al. in 2017 and can be seen in the image below<sup>[2]</sup>: 
                                    </p>
                                    <img src="https://static.igem.wiki/teams/4905/wiki/hp/vsd-afbeelding.png" class="center-image" style="width:40%; border-radius:10px; margin-bottom:10px"> 
                                    <p align="justify">
                                        The method helps our team to proactively consider the values of all stakeholders throughout the entire design process. For the stakeoldhers in the six stakeholder categories, we prioritized their values on a scale from 1-10, which we later on used to determine the direction that our project needed to go in. A rating of 1 means that the value is very unimportant to the stakeholder, while a 10 means that the value is extremely important to them. Moreover, it helped us to recognize conflicts between values and to prioritize which values should be integrated into our technology.
                                    </p>
                                    <p align="justify">
                                        We recognized the following values and design requirements during our project. In the section below, you can find for each value how important we found the values to be per stakeholder group. A meeting with <font color="#F6B227"><b>Zoë Robaey</font></b> helped us to find out which values are the most important in medical ethics. The ratings are based on the conversations we had with the stakeholders from the group. More information about the conversations we had with our stakeholders can be read in our <font color="#F6B227"><b>Interactive Timeline</font></b> below. Also, more information about what the value means, how important it became in our design, and how we incorporated it into our project can be read at each value analysis:
                                    </p>
                                    <p><h4>Safety and non-maleficence</h4></p>
                                    <img src="https://static.igem.wiki/teams/4905/wiki/hp/safety-and-non-malificence.svg" class="center-image" style="width:70%; border-radius:10px; margin-bottom:10px">
                                    <p align="justify">
                                        The most important value that was identified is <font color="#F6B227"><b>safety</font></b>, which is very closely related to <font color="#F6B227"><b>non-maleficence<sup></font></b><sup>[3]</sup>. Unsafe medication could cause harm or even death. The <font color="#F6B227"><b>WHO (World Health Organization)</font></b> has made a framework that contains all the important stakeholders and steps for safe medication. The Strategic Framework of the Global Patient Safety Challenge depicts the four domains of the Challenge: patients and the public, health care professionals, medicines and systems and practices of medication<sup>[4]</sup>. This framework shows that every stakeholder needs the final product and the production process to be safe from the production process up and until the treatment of the patient. This value has been a central part of conversations with many stakeholders from different sectors. We learned a lot about how to safely produce drugs via the GMP process from <font color="#F6B227"><b>BioConnection</font></b>. Furthermore, <font color="#F6B227"><b>RIVM</font></b> was able to tell us a lot more about the rules and regulations when it comes to bringing a therapy to market. Lastly, the <font color="#F6B227"><b>doctors and technical experts</font></b> we spoke to were able to point out some points in our design where safety could still use some improvements. 
                                    </p>
                                    <p align="justify">
                                        Some safety issues came up in our initial design that were addressed, such as horizontal gene transfer, where a plasmid might be taken up by another bacterium which could then start producing IL-10. An improvement of our design could be to move towards yeast in the future since we could then introduce introns in the plasmid, which will make other bacteria in the intestines unable to produce the protein. More information about this can be read on our <a style="color:#F6B227" href="https://2023.igem.wiki/tu-eindhoven/implementation"><i>Implemenation Page</i></a>.
                                    </p>
                                    <p align="justify">
                                        In another conversation about safety, Zoë pointed out to us that we are designing a vessel for drug delivery, and there needs to be control over who can decide what is incorporated into that vessel to make sure no harm can be done with our technology.
                                    </p>
                                    <p align="justify">
                                        Our meeting with <font color="#F6B227"><b>RIVM</font></b> revealed that the time the bacteria stay alive after ingestion is very important to know. The strain on the environment will be much lower if our bacteria only stay alive a couple of hours after ingestion but if they remain alive for days, they might produce IL-10 in nature which can have negative effects. Furthermore, they advised us to investigate what happens when the patient takes too much of the medication, or does not even need it at all.
                                    </p>
                                    <p><h4>Public health</h4></p>
                                    <img src="https://static.igem.wiki/teams/4905/wiki/hp/public-health.svg" class="center-image" style="width:70%; border-radius:10px; margin-bottom:10px">
                                    <p align="justify">
                                        <font color="#F6B227"><b>Public health</font></b> is another value that cannot be compromised in the design of a product. The value Public Health is defined as people with good complete physical, mental, and social well-being and not merely the absence of disease or infirmity as stated by <font color="#F6B227"><b>WHO</font></b><sup>[5]</sup>. Requirements for the value Public Health were explained to us by agencies such as <font color="#F6B227"><b>RIVM, VIG, doctors, and patients</font></b>. 
                                    </p>
                                    <p align="justify">
                                        To take the value public health into account, we have seen the need for our therapy to be <font color="#F6B227"><b>scalable</font></b>, so it will be accessible to the largest number of patients possible. Furthermore, <font color="#F6B227"><b>biocontainment</font></b> is an important requirement for public health as well. The living organisms that are ingested should not be able to survive outside of the body to reduce the chances of contamination. Additional research is needed to find out whether the organisms survive long enough in the intestines to come out alive. When this turns out to be the case, additional safety measures are needed. Lastly, the therapy should do <font color="#F6B227"><b>no harm</font></b> to the patient, which means that there should be no long-lasting side effects.
                                    </p>
                                    <p align="justify">
                                        We learned from <font color="#F6B227"><b>Peter from VIG</font></b> that it would be very beneficial to public health if the bacteria we produce can be stored in better conditions than the current alternative biologicals, this could make therapies more accessible for people who live in places that are harder to reach.
                                    </p>
                                    <p align="justify">
                                        Lastly, it is important to investigate whether the bacteria are still alive when they are passed from the intestines of the patient, because if they are alive in a sewage system, additional safety measurements might need to be taken. 
                                    </p>
                                    <p><h4>Beneficence</h4></p>
                                    <img src="https://static.igem.wiki/teams/4905/wiki/hp/beneficence.svg" class="center-image" style="width:70%; border-radius:10px; margin-bottom:10px">
                                    <p align="justify">
                                        The value <font color="#F6B227"><b>beneficence</font></b> requires that the procedure be provided with the intent of doing good for the patient involved<sup>[3]</sup>. Apart from that, we think that a new therapy will only be used by doctors and patients if it works better than the current accessible treatments. We analyzed together with experts and patients what points make our treatment more beneficial for patients than current treatments.
                                    </p>
                                    <p align="justify">
                                        One of the greatest benefits for patients and doctors is that our treatment design does not require patients to visit the hospital often. They can collect their prescription at the pharmacy, instead of having to go to the hospital and undergo injections every 8 weeks. This will <font color="#F6B227"><b>lessen the burden on hospitals and doctors</font></b> and at the same time make the treatment <font color="#F6B227"><b>less unpleasant</font></b> for patients.
                                    </p>
                                    <p><h4>Justice </h4></p>
                                    <img src="https://static.igem.wiki/teams/4905/wiki/hp/justice.svg" class="center-image" style="width:70%; border-radius:10px; margin-bottom:10px">
                                    <p align="justify">
                                        The value <font color="#F6B227"><b>justice</font></b> means that the burdens and benefits of new or experimental treatments must be distributed equally among all groups in society<sup>[3]</sup>. 
                                    </p>
                                    <p align="justify">
                                        To ensure our technology can be accessed by all people who need it, we have tried to make sure our product can be produced easily on a larger scale. This is one of the reasons that we chose to work with bacteria. Furthermore, we have been in touch with a <font color="#F6B227"><b>health insurance company</font></b> to find out what requirements there are before treatments can become part of health insurance. Our goal for the future is to make our treatment affordable and part of health insurance for every patient who needs it.
                                    </p>
                                    <p><h4>Autonomy </h4></p>
                                    <img src="https://static.igem.wiki/teams/4905/wiki/hp/autonomy.svg" class="center-image" style="width:70%; border-radius:10px; margin-bottom:10px">
                                    <p align="justify">
                                        Requires that the patient has <font color="#F6B227"><b>autonomy of thought, intention, and action</font></b> when making decisions regarding health care procedures<sup>[3]</sup>.  Therefore, the decision-making process must be free of coercion or coaxing.  In order for a patient to make a fully informed decision, they must understand all risks and benefits of the procedure and the likelihood of success.
                                    </p>
                                    <p align="justify">
                                        To keep this value in mind, we need to make sure that we well-inform doctors who are going to administer the therapy, so that they can properly discuss the risks and benefits with their patients. Furthermore, the prescription information needs to be clearly written.
                                    </p>
                                    <p><h4>Profitability</h4></p>
                                    <img src="https://static.igem.wiki/teams/4905/wiki/hp/profitability.svg" class="center-image" style="width:70%; border-radius:10px; margin-bottom:10px">
                                    <p align="justify">
                                        For a product to be viable on the market, it needs to be <font color="#F6B227"><b>profitable</font></b>. This means that profitability can also never be overlooked when designing a therapy. For as many people as possible to have access to our product, it needs to be scalable, which will in turn also <font color="#F6B227"><b>lower the production costs</font></b>. We think that our solution is much more scalable compared to other alternatives such as cell therapy and that production is easier than the production of antibodies, since we do not need human cell lines.
                                    </p>
                                    <p align="justify">
                                        This value is most important for the <font color="#F6B227"><b>business and industry partners</font></b> since if a company were arising from our project, or if another company should pick up our project, a profit needs to be made eventually. This means that the costs of production need to be significantly lower than what the customer is willing to pay for the product. To find out the costs of developing our project further, we talked to multiple experts, under which <font color="#F6B227"><b>BioConnection</font></b>, who do the fill and finish of drugs. They told us that the last production step of a small batch of our product will cost around 40,000 euros. Furthermore, <font color="#F6B227"><b>Maikel Peppelenbosch</font></b> has experience with running a clinical trial in research, he told us that a phase I clinical trial costs about 1,000,000 euros and that a phase II trial costs 10,000,000 euros. The numbers found in the literature were even higher<sup>[6]</sup>.
                                    </p>
                                    <p align="justify">
                                        At this stage of our project, however, profitability is not that important yet, since a <font color="#F6B227"><b>good proof of concept</font></b> is first needed. With that proof of concept, we want to look for <font color="#F6B227"><b>intellectual property</font></b> that we can use to file for a patent, which will help with profitability in the first years. However, we are aware that a patent cannot be granted anymore for anything disclosed in the iGEM competition. This means that first we need to <font color="#F6B227"><b>optimize</font></b> the product and find ways to patent the new parts. More about this can be read on our <a style="color:#F6B227" href="https://2023.igem.wiki/tu-eindhoven/implementation"><i>Implementation Page.</i></a>
                                    </p>
                                    <p align="justify">
                                        After this is achieved, the next step is to scale up the production process to where a high enough number of bacteria or yeast can be grown to make a product that can be distributed to many patients. The upscaling of bacterial growth has been applied before in the field of biomaterials for example and there is already literature that helps with how to scale up microbial processes<sup>[7][8]</sup>. More about upscaling and our business plan can be read in our <a style="color:#F6B227" href="https://2023.igem.wiki/tu-eindhoven/implementation"> <i>Implementation Page</i></a>.   
                                    </p>
                                    <p><h4>Innovation</h4></p>
                                    <img src="https://static.igem.wiki/teams/4905/wiki/hp/innovation.svg" class="center-image" style="width:70%; border-radius:10px; margin-bottom:10px">
                                    <p align="justify">
                                        <font color="#F6B227"><b>Innovation</font></b> is a very important aspect of a project to lift off in the early phases. For stakeholders to be interested, they need to see clearly that the concept is new and promising for the future. This is mostly important for the stakeholders who play a role in the beginning, such as our university TU-Eindhoven. 
                                    </p>
                                    <p align="justify">
                                        Our design is innovative since there are no patents on the technology yet and the formation of an intracellular hydrogel is a very <font color="#F6B227"><b>new concept</font></b>, it has never been achieved before with a protein engineering approach. 
                                    </p>
                                    <p><h4>Privacy</h4></p>
                                    <img src="https://static.igem.wiki/teams/4905/wiki/hp/privacy.svg" class="center-image" style="width:70%; border-radius:10px; margin-bottom:10px">
                                    <p align="justify">
                                        <font color="#F6B227"><b>Privacy</font></b> of patients should always be kept in mind when doing research on a new technology. This means that their data should be handled according to all regulations during clinical trials. This responsibility will lie mostly in the hands of the stakeholders who conduct the clinical trial, such as CHDR. We have conducted our own research amongst patients  and the general public as well in the form of a survey and had to make sure to keep their privacy in mind. Before conducting the survey, we consulted the <font color="#F6B227"><b>Ethical Review Committee</font></b> of our own university.
                                    </p>
                                    <p><h4>Conclusion and Outlook</h4></p>
                                    <p align="justify">
                                        Stakeholders often have value interests that align with each other, however for some there might be conflicts. Safety and profitability are in conflict with each other, since making the production process safer often means that the production costs will rise as well. However, we think there cannot be a compromise on safety and that this is much more important than profitability. This is why profitability will only become important at a later stage of the development of the design.
                                    </p>
                                    <p align="justify">
                                        As changes are made to the design, close contact with stakeholders will remain necessary to make sure that their most important needs are still met. And as soon as the values Safety, Beneficence, Public health, and Justice are well-incorporated in the design, it is possible to carry on with further <font color="#F6B227"><b>animal and patient studies</font></b>, and to perfect the production process to increase the profitability of cELPro.
                                    </p>
                                    <p><h4>Reflection</h4></p>
                                    <p align="justify">
                                        We discovered that for a project that is <font color="#F6B227"><b>good and responsible</font></b> for the world, you should always consider a <font color="#F6B227"><b>balance</font></b> between stakeholders and taking their values into account. It became apparent during the value-sensitive analysis that different stakeholders have different values leading to different design requirements. These design requirements can be in conflict and the goal is to meet the design requirements of all involved actors in such a way that the benefits for them are larger than the negative aspects. We tried to prioritize which stakeholders and values were the most important to try and keep most of them satisfied. This balance is something everybody in the iGEM community should keep in mind when they involve stakeholders in their project design. Future iGEM teams should not try to meet all design requirements, rather they should prioritize the requirements and try to satisfy the most relevant stakeholders first.
                                    </p>
                                </div>
                            </div>
                        </div>
                    </div>
                    </div>
                </div>
            
                <!-- Integrated Human Practices -->
                <div class="row mb-5 gx-0" id="inflammatory bowel disease">
                    <div class="col-1 d-flex justify-content-center">
                    <div class="line-description" style="height:100%;"></div>
                    </div>
                    <div class="col-10">
                    <div class="row gx-5">
            
                        <div class="col-12 mb-2">
                        <h2 id="text-to-link2 text-to-linkfleur1">Integrated Human Practices </h2>
                            <p align="justify" >
                                During our iGEM journey, we spoke to many <font color="#F6B227"><b>stakeholders</font></b> to get feedback on our project. Those stakeholders are divided into six categories: <font color="#F6B227"><b>science and research institutes, business and industry, laws and regulations, safety and ethics, public organizations and communities, and healthcare and hospitals</font></b>. More about the categories can be found below by <font color="#F6B227"><b>clicking</font></b> on the icons.  
                            </p>
                            <p align="justify">
                                An overview of the conversations can be seen in the interactive timeline beneath. The tools that we used in this timeline are the optimized <font color="#F6B227"><b>AREA framework</font></b> of the iGEM team TU Eindhoven 2022 and the <font color="#F6B227"><b>Gibbs Reflective Cycle</font></b>. More about these tools can be found in the respective sections.  Furthermore, please <font color="#F6B227"><b>click</font></b> the different stakeholder icons to learn more about them.
                            </p>                        
                        </div>
                    </div>
                    </div>
                </div>
            
                <!-- Dropdownmenus -->
                <div class="row mb-5 gx-0" id="background" style="position:relative">
                    <div id="background-reference"></div>
                    <div class="col-1 d-flex justify-content-center">
                    <div class="line-description" style="height:100%;"></div>
                    </div>
                    <div class="col-10">
                    <div class="row gx-5">
                        <div class="col-12 mb-2">
                            <!-- START dropdown-->
                            <button class="greendropdown">
                                <h5>AREA Framework</h5>
                                <div class="arrow-circle-lightgreen"></div>
                            </button>
                            <div class="panelblue">
                                <div style="padding:1.25em 0.5em;">
                                    <p align="justify">
                                        To integrate the feedback received from stakeholders it is important to close the engagement loop, different frameworks can be used for this. The AREA framework has been a commonly used framework among iGEM teams over the past few years. The TU Eindhoven 2022 team optimized this framework to the following four phases:   
                                    </p>
                                    <p>
                                        <font><b>1. Purpose</b></font>.  
                                        In this section, the relevance and motivation of the conversation with the stakeholder in question is described.   
                                    </p>
                                    <p>
                                        <font><b>2. Contribution</b></font>.  
                                        Here, the input of the stakeholder can be found, it summarizes the engagement and discussion we had. 
                                    </p>
                                    <p>
                                        <font><b>3. Implementation</b></font>. 
                                        This section shows how we implemented the feedback and how it influences our vision.
                                    </p>
                                    <p>
                                        <font><b>4. Outlook</b></font>.  
                                        Here, the next steps are described that the team has to take to further improve our project.  
                                    </p>
                                        
                                </div>
                            </div>

                            <!-- START dropdown-->
                            <button class="lightgreendropdown">
                                <h5>Gibbs Reflective Cycle</h5>
                                <div class="arrow-circle-green"></div>
                            </button>
                            <div class="panelblue">
                                <div style="padding:1.25em 0.5em;">
                                    <p align="justify">
                                        The Human Practices work over the past months had an effect on our project on different levels. Moreover, it made us able to make motivated decisions. After these big changes, we reflected on the decision that we made using the Gibbs reflective cycle. An overview of the steps of the cycle can be seen below.  
                                    </p>
                                    <div style="text-align:center;">
                                        <img src="https://static.igem.wiki/teams/4905/wiki/gibbs-reflective-cycle.svg" class="enlarge-image" style="width:450px; padding-bottom: 8px;">
                                    </div>                                    
                                </div>
                            </div>
                        </div>
                    </div>
                    </div>
                </div>
            </div>
        </div>


        <!-- Timeline -->



      <div class="row mb-5 gx-0" id="introduction">
        <div class="col-1 d-flex justify-content-center">
          <div class="line-description" style="height:100%;"></div>
        </div>
        <div class="col-10">
          <div class="row gx-5">

            <div class="col-12 mb-2">
              <div class="ag-timeline-block" style="max-width: 100%;">
  <div class="ag-timeline_title-box">
    <h2 style="text-align: center;"> Interactive timeline</h2>
    <p style="text-align: center;"> Click on each stakeholder to see how we implemented their feedback</p>
  </div>
  <section class="ag-section">
    <div class="ag-format-container">
      <div class="js-timeline ag-timeline">
        <div class="js-timeline_line ag-timeline_line">
          <div class="js-timeline_line-progress ag-timeline_line-progress"></div>
        </div>
        <div class="ag-timeline_list">
          <div class="js-timeline_item ag-timeline_item">
            <div class="ag-timeline-card_box">
              <div class="js-timeline-card_point-box ag-timeline-card_point-box">
                <div class="ag-timeline-card_point-blue">
                  <img src="https://static.igem.wiki/teams/4905/wiki/hp/hp/science.svg" style="width:60%; margin-top:-20%; margin-left: auto;" alt="stakeholder"/>
                </div>
              </div>
              <div class="ag-timeline-card_meta-box">
                <div class="ag-timeline-card_meta">June 13th</div>
              </div>
            </div>
            <div class="ag-timeline-card_item">
              <div class="ag-timeline-card_inner">
                <div class="ag-timeline-card_info">
                  <div class="ag-timeline-card_desc">
                    <div class="row">
                      <div class="col-lg-7 col-xs-12">
                        <h2>June 13th</h2>
                        <p style="margin-bottom: 0px">Jsoaper</p>
                        <p>Eindhoven University of Technology</p>
                        <p>Interview</p>
                      </div>
                      <div class="col-lg-5 col-xs-12">
                        <div class="ag-timeline-card_img-box">
                          <img src="https://static.igem.wiki/teams/5437/project/hp-page/jsoaper-logo.jpg" class="ag-timeline-card_img" alt="Meeting 1"/>
                        </div>
                      </div>
                    </div> 
                    <div class="row">
                      <div class="col-lg-12 col-xs-12">                   
                    <p align="justify">In this first meeting with the PIs we discussed the first potential project ideas. Based on the conversation we decided to perform extensive literature research on ELPs (Elastin-Like Polypeptides).</p>
                      </div>
                    </div>
                   
                  </div>
                </div>
              </div>
              <div class="ag-timeline-card_arrow"></div>
            </div>
          </div>

          <div class="js-timeline_item ag-timeline_item">
            <div class="ag-timeline-card_box">
              <div class="ag-timeline-card_meta-box">
                <div class="ag-timeline-card_meta">Juy 11</div>
              </div>
              <div class="js-timeline-card_point-box ag-timeline-card_point-box">
                <div class="ag-timeline-card_point-blue">
                  <img src="https://static.igem.wiki/teams/4905/wiki/hp/hp/science.svg" style="width:60%; margin-top:-20%; margin-left: auto;" alt="stakeholder"/>
                </div>
              </div>
            </div>
            <div class="ag-timeline-card_item">
              <div class="ag-timeline-card_inner">
                <div class="ag-timeline-card_info">
                  <div class="ag-timeline-card_desc">
                    <div class="row">
                      <div class="col-lg-5 col-xs-12">
                        <div class="ag-timeline-card_img-box">
                          <img src="https://static.igem.wiki/teams/5437/project/hp-page/download-11.jpg" class="ag-timeline-card_img" alt="Meeting 1"/>
                        </div>
                      </div>
                      <div class="col-lg-7 col-xs-12">
                        <h2>July 11</h2>
                        <p>Prof. Chen Jin-shen</p>
                        <p>Prof. Hsu Ming-jun</p>
                        <p>National Taiwan University - mosquito transmitted disease professors</p>
                      </div>
                    </div>   
                    <div class="row">
                      <div class="col-lg-12 col-xs-12">               
                        <p align="justify">We emailed these two professors to notify them of our project to understand the potental impact of our product and provide drylab techniques and equipment to test our repellent's effectiveness.</p>
                      </div>
                    </div>
        
                  </div>
                </div>
              </div>
              <div class="ag-timeline-card_arrow"></div>
            </div>
          </div>

          <div class="js-timeline_item ag-timeline_item">
            <div class="ag-timeline-card_box">
              <div class="js-timeline-card_point-box ag-timeline-card_point-box">
                <div class="ag-timeline-card_point-blue">
                  <img src="https://static.igem.wiki/teams/4905/wiki/hp/hp/science.svg" style="width:60%; margin-top:-20%; margin-left: auto;" alt="stakeholder"/>
                </div>
              </div>
              <div class="ag-timeline-card_meta-box">
                <div class="ag-timeline-card_meta">July 11</div>
              </div>
            </div>
            <div class="ag-timeline-card_item">
              <div class="ag-timeline-card_inner">
                <div class="ag-timeline-card_info">
                  <div class="ag-timeline-card_desc">
                    <div class="row">
                      <div class="col-lg-7 col-xs-12">
                        <h2>July nn </h2>
                        <p>Pharmacist Lin</p>
                      </div>
                      <div class="col-lg-5 col-xs-12">
                        <div class="ag-timeline-card_img-box">
                          <img src="https://static.igem.wiki/teams/4905/wiki/timeline/janvanhest2.svg" style="width:70%;" class="ag-timeline-card_img" alt="Meeting 1"/>
                        </div>
                      </div>
                    </div> 
                    <div class="row">
                      <div class="col-lg-12 col-xs-12">                   
                    <p align="justify">Through the interview with pharmacist Lin Yi-Wen, we received entrepreneurial advice on how to create a cosmetic product from the ground up. She also emphasized the importance of balancing efficacy and toxicity through comparing synthetic and natural repellents.</p>                    </p>
                      </div>
                    </div>
                   
                  </div>
                </div>
              </div>
              <div class="ag-timeline-card_arrow"></div>
            </div>
          </div>

          <div class="js-timeline_item ag-timeline_item">
            <div class="ag-timeline-card_box">
              <div class="ag-timeline-card_meta-box">
                <div class="ag-timeline-card_meta">July 26</div>
              </div>
              <div class="js-timeline-card_point-box ag-timeline-card_point-box">
                <div class="ag-timeline-card_point-blue">
                  <img src="https://static.igem.wiki/teams/4905/wiki/hp/hp/science.svg" style="width:60%; margin-top:-20%; margin-left: auto;" alt="stakeholder"/>
                </div>
              </div>
            </div>
            <div class="ag-timeline-card_item">
              <div class="ag-timeline-card_inner">
                <div class="ag-timeline-card_info">
                  <div class="ag-timeline-card_desc">
                    <div class="row">
                      <div class="col-lg-5 col-xs-12">
                        <div class="ag-timeline-card_img-box">
                          <img src="https://static.igem.wiki/teams/4905/wiki/timeline/imgmeeting1.svg" class="ag-timeline-card_img" alt="Meeting 1"/>
                        </div>
                      </div>
                      <div class="col-lg-7 col-xs-12">
                        <h2>July 26th</h2>
                        <p>Dr. Lin Yi-Wen</p>
                        <p>Dermatoligist, Yu Bin Clinic</p>
                        <p style="margin-bottom: 0px">We interviewed Dr. Lin, a dermatologist, in Yu Bin Clinic, and learned more about the adverse reactions that people in Taiwan have to mosquito bites. She also gave us insight on how the ingredients of current repellents are chosen.</p>
                        
                      </div>
                    </div>   
                    <div class="row">
                      <div class="col-lg-12 col-xs-12">               
                    <p align="justify"></p>
                      </div>
                    </div>
                    <div class="readmorehp" style="background-color:#445E93" id="hp4">Survey link</div>
                  </div>
                </div>
              </div>
              <div class="ag-timeline-card_arrow"></div>
            </div>
          </div>

          <!-- Reflection -->
          <div class="js-timeline_item ag-timeline_item">
            <div class="ag-timeline-card_box">
              <div class="js-timeline-card_point-box ag-timeline-card_point-box">
                <div class="ag-timeline-card_point-black">
                  <img src="https://static.igem.wiki/teams/4905/wiki/hp/hp/reflection.svg" style="width:60%; margin-top:-20%; margin-left: auto;" alt="stakeholder"/>
                </div>
              </div>
              <div class="ag-timeline-card_meta-box">
                <div class="ag-timeline-card_meta">Empty box</div>
              </div>
            </div>
            <div class="ag-timeline-card_item">
              <div class="ag-timeline-card_inner">
                <div class="ag-timeline-card_info">
                  <div class="ag-timeline-card_desc">
                   
                  </div>
                </div>
              </div>
              <div class="ag-timeline-card_arrow"></div>
            </div>
          </div>

          <div class="js-timeline_item ag-timeline_item">
            <div class="ag-timeline-card_box">
              <div class="ag-timeline-card_meta-box">
                <div class="ag-timeline-card_meta">July 27</div>
              </div>
              <div class="js-timeline-card_point-box ag-timeline-card_point-box">
                <div class="ag-timeline-card_point-yellow">
                  <img src="https://static.igem.wiki/teams/4905/wiki/hp/hp/laws.svg" style="width:80%; margin-top:-20%; margin-left: auto;" alt="stakeholder"/>
                </div>
              </div>
            </div>
            <div class="ag-timeline-card_item">
              <div class="ag-timeline-card_inner">
                <div class="ag-timeline-card_info">
                  <div class="ag-timeline-card_desc">
                    <div class="row">
                      <div class="col-lg-5 col-xs-12">
                        <div class="ag-timeline-card_img-box">
                          <img src="https://static.igem.wiki/teams/4905/wiki/timeline/natasa.svg" style="width:60%;"class="ag-timeline-card_img" alt="Meeting 1"/>
                        </div>
                      </div>
                      <div class="col-lg-7 col-xs-12">
                        <h2>July 27</h2>
                        <p>Dr. Chen Zhiqiang</p>
                      <p>Dermatologist</p>
                      </div>
                    </div> 
                    <div class="row">
                      <div class="col-lg-12 col-xs-12">                   
                    <p align="justify">During the interview with Dr. Chen, he gave suggestions about the inclusivity of our product, and sensitization.  We also learned about further potential methods to test the acceptable dosage of L-borneol in Borohma.</p>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
              <div class="ag-timeline-card_arrow"></div>
            </div>
          </div>

          <div class="js-timeline_item ag-timeline_item">
            <div class="ag-timeline-card_box">
              <div class="js-timeline-card_point-box ag-timeline-card_point-box">
                <div class="ag-timeline-card_point-pink">
                  <img src="https://static.igem.wiki/teams/4905/wiki/hp/hp/businesss.svg" style="width:60%; margin-top:-20%; margin-left: auto;" alt="stakeholder"/>
                </div>
              </div>
              <div class="ag-timeline-card_meta-box">
                <div class="ag-timeline-card_meta">April 10th</div>
              </div>
            </div>
            <div class="ag-timeline-card_item">
              <div class="ag-timeline-card_inner">
                <div class="ag-timeline-card_info">
                  <div class="ag-timeline-card_desc">
                    <div class="row">
                      <div class="col-lg-7 col-xs-12">
                        <h2>April 10th</h2>
                        <p>Diego Lopez Barreiro</p>
                        <p>Large Dutch chemical company</p>
                        <p>Modeling expert on ELPs</p>
                      </div>
                      <div class="col-lg-5 col-xs-12">
                        <div class="ag-timeline-card_img-box">
                          <img src="https://static.igem.wiki/teams/4905/wiki/diego.jpeg" style="width:70%; border-radius:50%;" class="ag-timeline-card_img" alt="Meeting 1"/>
                        </div>
                      </div>
                    </div> 
                    <div class="row">
                      <div class="col-lg-12 col-xs-12">                   
                    <p align="justify">Diego explained to us how we can develop a molecular dynamics simulation to support our project. He provided us with a guide that has a step-by-step explanation of how to do molecular dynamics simulations. </p>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
              <div class="ag-timeline-card_arrow"></div>
            </div>
          </div>

          <div class="js-timeline_item ag-timeline_item">
            <div class="ag-timeline-card_box">
              <div class="ag-timeline-card_meta-box">
                <div class="ag-timeline-card_meta">April 11th</div>
              </div>
              <div class="js-timeline-card_point-box ag-timeline-card_point-box">
                <div class="ag-timeline-card_point-pink">
                  <img src="https://static.igem.wiki/teams/4905/wiki/hp/hp/businesss.svg" style="width:60%; margin-top:-20%; margin-left: auto;" alt="stakeholder"/>
                </div>
              </div>
            </div>
            <div class="ag-timeline-card_item">
              <div class="ag-timeline-card_inner">
                <div class="ag-timeline-card_info">
                  <div class="ag-timeline-card_desc">
                    <div class="row">
                      <div class="col-lg-5 col-xs-12">
                        <div class="ag-timeline-card_img-box">
                          <img src="https://static.igem.wiki/teams/4905/wiki/timeline/paul.svg" style="width:70%;"class="ag-timeline-card_img" alt="Meeting 1"/>
                        </div>
                      </div>
                      <div class="col-lg-7 col-xs-12">
                        <h2>April 11th</h2>
                        <p>Paul van Zutphen</p>
                        <p>BioConnection</p>
                        <p>GMP on large scale</p>
                      </div>
                    </div>   
                    <div class="row">
                      <div class="col-lg-12 col-xs-12">               
                    <p align="justify">Paul told us to narrow down the scope of our project and think of what the production process may look like. </p>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
              <div class="ag-timeline-card_arrow"></div>
            </div>
          </div>

          <div class="js-timeline_item ag-timeline_item">
            <div class="ag-timeline-card_box">
              <div class="js-timeline-card_point-box ag-timeline-card_point-box">
                <div class="ag-timeline-card_point-pink">
                  <img src="https://static.igem.wiki/teams/4905/wiki/hp/hp/businesss.svg" style="width:60%; margin-top:-20%; margin-left: auto;" alt="stakeholder"/>
                </div>
              </div>
              <div class="ag-timeline-card_meta-box">
                <div class="ag-timeline-card_meta">April 11th</div>
              </div>
            </div>
            <div class="ag-timeline-card_item">
              <div class="ag-timeline-card_inner">
                <div class="ag-timeline-card_info">
                  <div class="ag-timeline-card_desc">
                    <div class="row">
                      <div class="col-lg-7 col-xs-12">
                        <h2>April 11th</h2>
                        <p>Unknown employee</p>
                        <p>Medtronic</p>
                        <p>Med tech company</p>
                      </div>
                      <div class="col-lg-5 col-xs-12">
                        <div class="ag-timeline-card_img-box">
                          <img src="https://static.igem.wiki/teams/4905/wiki/timeline/medtronic.svg" style="width:70%;" class="ag-timeline-card_img" alt="Meeting 1"/>
                        </div>
                      </div>
                    </div> 
                    <div class="row">
                      <div class="col-lg-12 col-xs-12">                   
                    <p align="justify">The employee from Medtronic advised us to narrow down our project so that we can find the right application.</p>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
              <div class="ag-timeline-card_arrow"></div>
            </div>
          </div>

          <div class="js-timeline_item ag-timeline_item">
            <div class="ag-timeline-card_box">
              <div class="ag-timeline-card_meta-box">
                <div class="ag-timeline-card_meta">April 12th</div>
              </div>
              <div class="js-timeline-card_point-box ag-timeline-card_point-box">
                <div class="ag-timeline-card_point-blue">
                  <img src="https://static.igem.wiki/teams/4905/wiki/hp/hp/science.svg" style="width:60%; margin-top:-20%; margin-left: auto;" alt="stakeholder"/>
                </div>
              </div>
            </div>
            <div class="ag-timeline-card_item">
              <div class="ag-timeline-card_inner">
                <div class="ag-timeline-card_info">
                  <div class="ag-timeline-card_desc">
                    <div class="row">
                      <div class="col-lg-5 col-xs-12">
                        <div class="ag-timeline-card_img-box">
                          <img src="https://static.igem.wiki/teams/4905/wiki/timeline/tue.svg" class="ag-timeline-card_img" alt="Meeting 1"/>
                        </div>
                      </div>
                      <div class="col-lg-7 col-xs-12">
                        <h2>April 12th</h2>
                        <p style="margin-bottom: 0px">Prof. Dr. Ir. Luc Brunsveld</p>
                        <p style="margin-top: 0px; margin-bottom: 0px">Prof. Dr. Maarten Merkx</p>
                        <p style="margin-top: 0px; margin-bottom: 0px">Prof. Dr. Ir. Tom de Greef</p>
                        <p style="margin-top: 0px; margin-bottom: 0px">Ir. Thijs van Veldhuisen</p>
                        <p style="margin-top: 0px; margin-bottom: 0px">Postdoc. Eduardo Guisasola</p>
                        <p style="margin-top: 0px">Postdoc. Huynh Tien Duc Le</p>
                        <p>Eindhoven University of Technology</p>
                        <p>PIs and Lab supervisors</p>
                      </div>
                    </div>   
                    <div class="row">
                      <div class="col-lg-12 col-xs-12">               
                    <p align="justify">The supervisors gave us the necessary information to get started in the lab. Moreover, together we came up with the idea to use the intracellular hydrogelated cells as probiotics.</p>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
              <div class="ag-timeline-card_arrow"></div>
            </div>
          </div>

          <!-- Reflection -->
          <div class="js-timeline_item ag-timeline_item">
            <div class="ag-timeline-card_box">
              <div class="js-timeline-card_point-box ag-timeline-card_point-box">
                <div class="ag-timeline-card_point-black">
                  <img src="https://static.igem.wiki/teams/4905/wiki/hp/hp/reflection.svg" style="width:60%; margin-top:-20%; margin-left: auto;" alt="stakeholder"/>
                </div>
              </div>
              <div class="ag-timeline-card_meta-box">
                <div class="ag-timeline-card_meta">Reflection</div>
              </div>
            </div>
            <div class="ag-timeline-card_item">
              <div class="ag-timeline-card_inner">
                <div class="ag-timeline-card_info">
                  <div class="ag-timeline-card_desc">
                    <div class="readmorehp" style="background-color:#000000" id="hp51">Click to read reflection 2</div>
                  </div>
                </div>
              </div>
              <div class="ag-timeline-card_arrow"></div>
            </div>
          </div>

          <div class="js-timeline_item ag-timeline_item">
            <div class="ag-timeline-card_box">
              <div class="ag-timeline-card_meta-box">
                <div class="ag-timeline-card_meta">May 30th</div>
              </div>
              <div class="js-timeline-card_point-box ag-timeline-card_point-box">
                <div class="ag-timeline-card_point-blue">
                  <img src="https://static.igem.wiki/teams/4905/wiki/hp/hp/science.svg" style="width:60%; margin-top:-20%; margin-left: auto;" alt="stakeholder"/>
                </div>
              </div>
            </div>
            <div class="ag-timeline-card_item">
              <div class="ag-timeline-card_inner">
                <div class="ag-timeline-card_info">
                  <div class="ag-timeline-card_desc">
                    <div class="row">
                      <div class="col-lg-5 col-xs-12">
                        <div class="ag-timeline-card_img-box">
                          <img src="https://static.igem.wiki/teams/4905/wiki/timeline/gijsje.svg" style="width:70%;"class="ag-timeline-card_img" alt="Meeting 1"/>
                        </div>
                      </div>
                      <div class="col-lg-7 col-xs-12">
                        <h2>May 30th</h2>
                        <p>Prof. Dr. Gijsje Koenderink</p>
                        <p>University of Technology Delft</p>
                        <p>Bionanoscience</p>
                      </div>
                    </div> 
                    <div class="row">
                      <div class="col-lg-12 col-xs-12">                   
                    <p align="justify">Gijsje pointed out that is important to really get clear what the benefits of our technique are compared to other techniques such as nanoparticles.</p>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
              <div class="ag-timeline-card_arrow"></div>
            </div>
          </div>

          <div class="js-timeline_item ag-timeline_item">
            <div class="ag-timeline-card_box">
              <div class="js-timeline-card_point-box ag-timeline-card_point-box">
                <div class="ag-timeline-card_point-green">
                  <img src="https://static.igem.wiki/teams/4905/wiki/hp/hp/health.svg" style="width:60%; margin-top:-20%; margin-left: auto;" alt="stakeholder"/>
                </div>
              </div>
              <div class="ag-timeline-card_meta-box">
                <div class="ag-timeline-card_meta">June 8th</div>
              </div>
            </div>
            <div class="ag-timeline-card_item">
              <div class="ag-timeline-card_inner">
                <div class="ag-timeline-card_info">
                  <div class="ag-timeline-card_desc">
                    <div class="row">
                      <div class="col-lg-7 col-xs-12">
                        <h2>June 8th</h2>
                        <p>Drs. Monique Devillers</p>
                        <p>Erasmus MC</p>
                        <p>Physician-researcher stomach, intestine, and liver diseases (specialized in IBD)</p>
                      </div>   
                      <div class="col-lg-5 col-xs-12">
                        <div class="ag-timeline-card_img-box">
                          <img src="https://static.igem.wiki/teams/4905/wiki/timeline/erasmus.svg" style="width:80%;"class="ag-timeline-card_img" alt="Meeting 1"/>
                        </div>
                      </div>
                    </div>
                    <div class="row">
                      <div class="col-lg-12 col-xs-12">               
                    <p align="justify">Current treatments of IBD are often effective but are expensive and still give many side effects because they are not specific enough. For many patients there still is no suitable treatment.</p>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
              <div class="ag-timeline-card_arrow"></div>
            </div>
          </div>

          <!-- Reflection -->
          <div class="js-timeline_item ag-timeline_item">
            <div class="ag-timeline-card_box">
              <div class="ag-timeline-card_meta-box">
                <div class="ag-timeline-card_meta">Reflection</div>
              </div>
              <div class="js-timeline-card_point-box ag-timeline-card_point-box">
                <div class="ag-timeline-card_point-black">
                  <img src="https://static.igem.wiki/teams/4905/wiki/hp/hp/reflection.svg" style="width:60%; margin-top:-20%; margin-left: auto;" alt="stakeholder"/>
                </div>
              </div>
            </div>
            <div class="ag-timeline-card_item">
              <div class="ag-timeline-card_inner">
                <div class="ag-timeline-card_info">
                  <div class="ag-timeline-card_desc">
                    <div class="readmorehp" style="background-color:#000000" id="hp52">Click to read reflection 3</div>
                  </div>
                </div>
              </div>
              <div class="ag-timeline-card_arrow"></div>
            </div>
          </div>


          <div class="js-timeline_item ag-timeline_item">
            <div class="ag-timeline-card_box">
              <div class="js-timeline-card_point-box ag-timeline-card_point-box">
                <div class="ag-timeline-card_point-pink">
                  <img src="https://static.igem.wiki/teams/4905/wiki/hp/hp/businesss.svg" style="width:60%; margin-top:-20%; margin-left: auto;" alt="stakeholder"/>
                </div>
              </div>
              <div class="ag-timeline-card_meta-box">
                <div class="ag-timeline-card_meta">June 16th</div>
              </div>
            </div>
            <div class="ag-timeline-card_item">
              <div class="ag-timeline-card_inner">
                <div class="ag-timeline-card_info">
                  <div class="ag-timeline-card_desc">
                    <div class="row">
                      <div class="col-lg-6 col-xs-12">
                        <h2>June 16th</h2>
                        <p style="margin-bottom: 0px">Paul van Zutphen</p>
                        <p style="margin-top: 0px">Dr. Alexander Willemse</p>
                        <p>BioConnection</p>
                        <p>GMP on large scale</p>
                      </div>
                      <div class="col-lg-5 col-xs-12">
                        <div class="ag-timeline-card_img-box">
                          <img src="https://static.igem.wiki/teams/4905/wiki/timeline/alexanderandpaul.svg" style="width:100%;" class="ag-timeline-card_img" alt="Meeting 1"/>
                        </div>
                      </div>
                    </div> 
                    <div class="row">
                      <div class="col-lg-12 col-xs-12">                   
                    <p align="justify">Paul and Alexander made us aware of the potential strategies for the pill design for hydrocells, such as freeze-drying of the bacteria and a pH-sensitive coating. Furthermore, they told us more about the GMP process and its costs.</p>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
              <div class="ag-timeline-card_arrow"></div>
            </div>
          </div>

          <div class="js-timeline_item ag-timeline_item">
            <div class="ag-timeline-card_box">
              <div class="ag-timeline-card_meta-box">
                <div class="ag-timeline-card_meta">June 16th</div>
              </div>
              <div class="js-timeline-card_point-box ag-timeline-card_point-box">
                <div class="ag-timeline-card_point-blue">
                  <img src="https://static.igem.wiki/teams/4905/wiki/hp/hp/science.svg" style="width:60%; margin-top:-20%; margin-left: auto;" alt="stakeholder"/>
                </div>
              </div>
            </div>
            <div class="ag-timeline-card_item">
              <div class="ag-timeline-card_inner">
                <div class="ag-timeline-card_info">
                  <div class="ag-timeline-card_desc">
                    <div class="row">
                      <div class="col-lg-5 col-xs-12">
                        <div class="ag-timeline-card_img-box">
                          <img src="https://static.igem.wiki/teams/4905/wiki/timeline/ucdavis.svg" style="width:70%;"class="ag-timeline-card_img" alt="Meeting 1"/>
                        </div>
                      </div>
                      <div class="col-lg-7 col-xs-12">
                        <h2>June 16th</h2>
                        <p style="margin-bottom: 0px">Dr. Cheemeng Tan</p>
                        <p style="margin-top: 0px">Dr. Luis Eduardo Contreras Llano</p>
                        <p>University of California Davis</p>
                        <p>Synthetic Biology</p>
                      </div>  
                    </div>
                    <div class="row">
                      <div class="col-lg-12 col-xs-12">               
                    <p align="justify">We will probably still come across some technical challenges that we have to solve but overall, the stakeholders were excited about our initiative.</p>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
              <div class="ag-timeline-card_arrow"></div>
            </div>
          </div>

          <div class="js-timeline_item ag-timeline_item">
            <div class="ag-timeline-card_box">
              <div class="js-timeline-card_point-box ag-timeline-card_point-box">
                <div class="ag-timeline-card_point-green">
                  <img src="https://static.igem.wiki/teams/4905/wiki/hp/hp/health.svg" style="width:60%; margin-top:-20%; margin-left: auto;" alt="stakeholder"/>
                </div>
              </div>
              <div class="ag-timeline-card_meta-box">
                <div class="ag-timeline-card_meta">June 22nd</div>
              </div>
            </div>
            <div class="ag-timeline-card_item">
              <div class="ag-timeline-card_inner">
                <div class="ag-timeline-card_info">
                  <div class="ag-timeline-card_desc">
                    <div class="row">
                      <div class="col-lg-7 col-xs-12">
                        <h2>June 22nd</h2>
                        <p>Dr. Gewnny Fuhler</p>
                        <p>Erasmus MC</p>
                        <p>Gastroenterology & Hepatology</p>
                      </div>
                      <div class="col-lg-5 col-xs-12">
                        <div class="ag-timeline-card_img-box">
                          <img src="https://static.igem.wiki/teams/4905/wiki/timeline/gwenny.svg" style="width:80%;"class="ag-timeline-card_img" alt="Meeting 1"/>
                        </div>
                      </div>
                    </div> 
                    <div class="row">
                      <div class="col-lg-12 col-xs-12">                   
                    <p align="justify">Gwenny gave us her opinion about the molecular targets that we had selected until now. Before the meeting, we wanted to go for making an anti TNF-alpha antibody, however she pointed out that this might not be the best choice. We found out that we have to look into molecular targets again and that IL-10 and JAK/STAT inhibitors might be interesting.</p>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
              <div class="ag-timeline-card_arrow"></div>
            </div>
          </div>

          <div class="js-timeline_item ag-timeline_item">
            <div class="ag-timeline-card_box">
              <div class="ag-timeline-card_meta-box">
                <div class="ag-timeline-card_meta">July 6th</div>
              </div>
              <div class="js-timeline-card_point-box ag-timeline-card_point-box">
                <div class="ag-timeline-card_point-green">
                  <img src="https://static.igem.wiki/teams/4905/wiki/hp/hp/health.svg" style="width:60%; margin-top:-20%; margin-left: auto;" alt="stakeholder"/>
                </div>
              </div>
            </div>
            <div class="ag-timeline-card_item">
              <div class="ag-timeline-card_inner">
                <div class="ag-timeline-card_info">
                  <div class="ag-timeline-card_desc">
                    <div class="row">
                      <div class="col-lg-5 col-xs-12">
                        <div class="ag-timeline-card_img-box">
                          <img src="https://static.igem.wiki/teams/4905/wiki/timeline/maikel.svg" style="width:80%;"class="ag-timeline-card_img" alt="Meeting 1"/>
                        </div>
                      </div>
                      <div class="col-lg-7 col-xs-12">
                        <h2>July 6th</h2>
                        <p>Prof. Dr. Maikel Peppelenbosch</p>
                        <p>Erasmus MC</p>
                        <p>Head of the laboratory Gastroenterology and Hepatology</p>
                      </div>
                    </div>   
                    <div class="row">
                      <div class="col-lg-12 col-xs-12">               
                    <p align="justify">Professor Peppelenbosch gave us an insight into his experiences of the phase 1 clinical trial he did with a bacterial therapy for IBD excreting interleukin 10. Moreover, he gave us his critical opinion on our project and gave new advice on how to make the platform safer.</p>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
              <div class="ag-timeline-card_arrow"></div>
            </div>
          </div>

          <div class="js-timeline_item ag-timeline_item">
            <div class="ag-timeline-card_box">
              <div class="js-timeline-card_point-box ag-timeline-card_point-box">
                <div class="ag-timeline-card_point-lightgreen">
                  <img src="https://static.igem.wiki/teams/4905/wiki/hp/hp/safety.svg" style="width:60%; margin-top:-20%; margin-left: auto;" alt="stakeholder"/>
                </div>
              </div>
              <div class="ag-timeline-card_meta-box">
                <div class="ag-timeline-card_meta">July 20th</div>
              </div>
            </div>
            <div class="ag-timeline-card_item">
              <div class="ag-timeline-card_inner">
                <div class="ag-timeline-card_info">
                  <div class="ag-timeline-card_desc">
                    <div class="row">
                      <div class="col-lg-7 col-xs-12">
                        <h2>July 20th</h2>
                        <p>Dr. Zoë Robaey</p>
                        <p>Wageningen University</p>
                        <p>Ethics of GMOs</p>
                      </div>
                      <div class="col-lg-5 col-xs-12">
                        <div class="ag-timeline-card_img-box">
                          <img src="https://static.igem.wiki/teams/4905/wiki/timeline/zoe.svg" style="width:80%;"class="ag-timeline-card_img" alt="Meeting 1"/>
                        </div>
                      </div>
                    </div> 
                    <div class="row">
                      <div class="col-lg-12 col-xs-12">                   
                    <p align="justify">Keep in mind the four principles of medical ethics in your design and think of who will get to decide what the bacteria can produce.</p>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
              <div class="ag-timeline-card_arrow"></div>
            </div>
          </div>

          <!-- Reflection -->
          <div class="js-timeline_item ag-timeline_item">
            <div class="ag-timeline-card_box">
              <div class="ag-timeline-card_meta-box">
                <div class="ag-timeline-card_meta">Reflection</div>
              </div>
              <div class="js-timeline-card_point-box ag-timeline-card_point-box">
                <div class="ag-timeline-card_point-black">
                  <img src="https://static.igem.wiki/teams/4905/wiki/hp/hp/reflection.svg" style="width:60%; margin-top:-20%; margin-left: auto;" alt="stakeholder"/>
                </div>
              </div>
            </div>
            <div class="ag-timeline-card_item">
              <div class="ag-timeline-card_inner">
                <div class="ag-timeline-card_info">
                  <div class="ag-timeline-card_desc">
                    <div class="readmorehp" style="background-color:#000000" id="hp53">Click to read reflection 4</div>
                  </div>
                </div>
              </div>
              <div class="ag-timeline-card_arrow"></div>
            </div>
          </div>

          <div class="js-timeline_item ag-timeline_item">
            <div class="ag-timeline-card_box">
              <div class="js-timeline-card_point-box ag-timeline-card_point-box">
                <div class="ag-timeline-card_point-lightgreen">
                  <img src="https://static.igem.wiki/teams/4905/wiki/hp/hp/safety.svg" style="width:60%; margin-top:-20%; margin-left: auto;" alt="stakeholder"/>
                </div>
              </div>
              <div class="ag-timeline-card_meta-box">
                <div class="ag-timeline-card_meta">July 24th</div>
              </div>
            </div>
            <div class="ag-timeline-card_item">
              <div class="ag-timeline-card_inner">
                <div class="ag-timeline-card_info">
                  <div class="ag-timeline-card_desc">
                    <div class="row">
                      <div class="col-lg-7 col-xs-12">
                        <h2>July 24th</h2>
                        <p style="margin-bottom: 0px">Dr. ir. Céclile van der Vlught-Bergmans </p>
                        <p style="margin-top: 0px">Dr. Mirjam Schuijff</p>                        
                        <p>RIVM</p>
                        <p>Safety of Biotechnology & Safe-by-Design  </p>
                      </div>
                      <div class="col-lg-5 col-xs-12">
                        <div class="ag-timeline-card_img-box">
                          <img src="https://static.igem.wiki/teams/4905/wiki/timeline/rivm.svg" class="ag-timeline-card_img" alt="Meeting 1"/>
                        </div>
                      </div>
                    </div>   
                    <div class="row">
                      <div class="col-lg-12 col-xs-12">               
                    <p align="justify">With Cécile and Mirjam we spoke about the risk assessment that is done for every new medicine, they gave us an overview about what components of our project need to be confirmed to be safe for human use. However, they were positive about the concept and saw a new method to potentially treat a variety of diseases.  </p>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
              <div class="ag-timeline-card_arrow"></div>
            </div>
          </div>

          <div class="js-timeline_item ag-timeline_item">
            <div class="ag-timeline-card_box">
              <div class="ag-timeline-card_meta-box">
                <div class="ag-timeline-card_meta">August 16th</div>
              </div>
              <div class="js-timeline-card_point-box ag-timeline-card_point-box">
                <div class="ag-timeline-card_point-yellow">
                  <img src="https://static.igem.wiki/teams/4905/wiki/hp/hp/laws.svg" style="width:60%; margin-top:-20%; margin-left: auto;" alt="stakeholder"/>
                </div>
              </div>
            </div>
            <div class="ag-timeline-card_item">
              <div class="ag-timeline-card_inner">
                <div class="ag-timeline-card_info">
                  <div class="ag-timeline-card_desc">
                    <div class="row">
                      <div class="col-lg-5 col-xs-12">
                        <div class="ag-timeline-card_img-box">
                          <img src="https://static.igem.wiki/teams/4905/wiki/timeline/jos.svg" style="width:80%;"class="ag-timeline-card_img" alt="Meeting 1"/>
                        </div>
                      </div>
                      <div class="col-lg-7 col-xs-12">
                        <h2>August 16th</h2>
                        <p>Jos van der Wijst</p>
                        <p>BG Legal</p>
                        <p>Intellectual property for tech startup/scale-up companies</p>
                      </div>
                    </div> 
                    <div class="row">
                      <div class="col-lg-12 col-xs-12">                   
                    <p align="justify">With Jos, we spoke about the possible IP strategies of cELPro. Although the iGEM competition is open source, he advised us to always have something in reserve to protect the technology.</p>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
              <div class="ag-timeline-card_arrow"></div>
            </div>
          </div>

          <div class="js-timeline_item ag-timeline_item">
            <div class="ag-timeline-card_box">
              <div class="js-timeline-card_point-box ag-timeline-card_point-box">
                <div class="ag-timeline-card_point-white">
                  <img src="https://static.igem.wiki/teams/4905/wiki/hp/hp/public.svg" style="width:60%; margin-top:-20%; margin-left: auto;" alt="stakeholder"/>
                </div>
              </div>
              <div class="ag-timeline-card_meta-box">
                <div class="ag-timeline-card_meta">August 20th</div>
              </div>
            </div>
            <div class="ag-timeline-card_item">
              <div class="ag-timeline-card_inner">
                <div class="ag-timeline-card_info">
                  <div class="ag-timeline-card_desc">
                    <div class="row">
                      <div class="col-lg-7 col-xs-12">
                        <h2>August 20th</h2>
                        <p>General members of the public </p>                       
                      </div>
                      <div class="col-lg-5 col-xs-12"></div>
                    </div>   
                    <div class="row">
                      <div class="col-lg-12 col-xs-12">               
                    <p align="justify">We asked several people, ranging in age and education level, about their opinions of the use of GMOs as a treatment. Even though the public thought there would be a contrast in opinions based on the educational level, there was no significant difference.   </p>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
              <div class="ag-timeline-card_arrow"></div>
            </div>
          </div>

          <div class="js-timeline_item ag-timeline_item">
            <div class="ag-timeline-card_box">
              <div class="ag-timeline-card_meta-box">
                <div class="ag-timeline-card_meta">August 25th</div>
              </div>
              <div class="js-timeline-card_point-box ag-timeline-card_point-box">
                <div class="ag-timeline-card_point-white">
                  <img src="https://static.igem.wiki/teams/4905/wiki/hp/hp/public.svg" style="width:60%; margin-top:-20%; margin-left: auto;" alt="stakeholder"/>
                </div>
              </div>
            </div>
            <div class="ag-timeline-card_item">
              <div class="ag-timeline-card_inner">
                <div class="ag-timeline-card_info">
                  <div class="ag-timeline-card_desc">
                    <div class="row">
                      <div class="col-lg-5 col-xs-12">
                        <div class="ag-timeline-card_img-box">
                          <img src="https://static.igem.wiki/teams/4905/wiki/timeline/crohncolitis.svg" style="width:60%;"class="ag-timeline-card_img" alt="Meeting 1"/>
                        </div>
                      </div>
                      <div class="col-lg-7 col-xs-12">
                        <h2>August 25th</h2>
                        <p>IBD patients</p>
                        <p>Crohn & Colitis NL </p>
                      </div>
                    </div> 
                    <div class="row">
                      <div class="col-lg-12 col-xs-12">                   
                    <p align="justify">In July, we contacted the Dutch Crohn’s & Colitis Foundation and asked them if it would be possible to share a survey on their social media. This was done to find out what the impact of IBD is on patient’s life, and how IBD patients would feel about cELPro. They kindly agreed, and posted the survey on their social media in August. In the span of a few days, we got nearly 200 responses from IBD patients.  </p>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
              <div class="ag-timeline-card_arrow"></div>
            </div>
          </div>

          <div class="js-timeline_item ag-timeline_item">
            <div class="ag-timeline-card_box">
              <div class="js-timeline-card_point-box ag-timeline-card_point-box">
                <div class="ag-timeline-card_point-yellow">
                  <img src="https://static.igem.wiki/teams/4905/wiki/hp/hp/laws.svg" style="width:60%; margin-top:-20%; margin-left: auto;" alt="stakeholder"/>
                </div>
              </div>
              <div class="ag-timeline-card_meta-box">
                <div class="ag-timeline-card_meta">August 29th</div>
              </div>
            </div>
            <div class="ag-timeline-card_item">
              <div class="ag-timeline-card_inner">
                <div class="ag-timeline-card_info">
                  <div class="ag-timeline-card_desc">
                    <div class="row">
                      <div class="col-lg-7 col-xs-12">
                        <h2>August 29th</h2>
                        <p>Peter Bertens</p>                        
                        <p>VIG</p>
                        <p>Microbiologist who is occupied with laws and regulations for innovative medicine</p>
                      </div>
                      <div class="col-lg-5 col-xs-12">
                        <div class="ag-timeline-card_img-box">
                          <img src="https://static.igem.wiki/teams/4905/wiki/timeline/peterbertens.svg" style="width:90%;"class="ag-timeline-card_img" alt="Meeting 1"/>
                        </div>
                      </div>
                    </div>   
                    <div class="row">
                      <div class="col-lg-12 col-xs-12">               
                    <p align="justify">With Peter, we discussed what steps are required for a new type of drug to be approved. Furthermore, we talked about the laws and regulations for GMOs.</p>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
              <div class="ag-timeline-card_arrow"></div>
            </div>
          </div>

          <div class="js-timeline_item ag-timeline_item">
            <div class="ag-timeline-card_box">
              <div class="ag-timeline-card_meta-box">
                <div class="ag-timeline-card_meta">September 19th</div>
              </div>
              <div class="js-timeline-card_point-box ag-timeline-card_point-box">
                <div class="ag-timeline-card_point-yellow">
                  <img src="https://static.igem.wiki/teams/4905/wiki/hp/hp/laws.svg" style="width:60%; margin-top:-20%; margin-left: auto;" alt="stakeholder"/>
                </div>
              </div>
            </div>
            <div class="ag-timeline-card_item">
              <div class="ag-timeline-card_inner">
                <div class="ag-timeline-card_info">
                  <div class="ag-timeline-card_desc">
                    <div class="row">
                      <div class="col-lg-5 col-xs-12">
                        <div class="ag-timeline-card_img-box">
                          <img src="https://static.igem.wiki/teams/4905/wiki/timeline/leegmens.svg" style="width:50%;"class="ag-timeline-card_img" alt="Meeting 1"/>
                        </div>
                      </div>
                      <div class="col-lg-7 col-xs-12">
                        <h2>September 19th</h2>
                        <p>Anonymous</p>
                        <p>Health insurance company</p>
                        <p>Advisor</p>
                      </div>
                    </div> 
                    <div class="row">
                      <div class="col-lg-12 col-xs-12">                   
                    <p align="justify">The health insurance employee told us about when medications are covered by insurance, when patients have to pay, and where to find the cost of all medications in The Netherlands.  </p>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
              <div class="ag-timeline-card_arrow"></div>
            </div>
          </div>

          <div class="js-timeline_item ag-timeline_item">
            <div class="ag-timeline-card_box">
              <div class="js-timeline-card_point-box ag-timeline-card_point-box">
                <div class="ag-timeline-card_point-white">
                  <img src="https://static.igem.wiki/teams/4905/wiki/hp/hp/public.svg" style="width:60%; margin-top:-20%; margin-left: auto;" alt="stakeholder"/>
                </div>
              </div>
              <div class="ag-timeline-card_meta-box">
                <div class="ag-timeline-card_meta">September 19th</div>
              </div>
            </div>
            <div class="ag-timeline-card_item">
              <div class="ag-timeline-card_inner">
                <div class="ag-timeline-card_info">
                  <div class="ag-timeline-card_desc">
                    <div class="row">
                      <div class="col-lg-7 col-xs-12">
                        <h2>September 19th</h2>
                        <p>Patient 1 </p>                    
                      </div>
                      <div class="col-lg-5 col-xs-12"></div>
                    </div>   
                    <div class="row">
                      <div class="col-lg-12 col-xs-12">               
                    <p align="justify">The patient told us about the impact of IBD on her life. She said that aside from the pain, what makes it really difficult is mostly the fact that everything needs to be carefully thought about and planned. She said that most of the medication causes extreme fatigue and starts working less overtime. She thinks a new medicine that is suitable for longer or permanent use where the quality of daily life would still be reasonable would be most valuable. </p>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
              <div class="ag-timeline-card_arrow"></div>
            </div>
          </div>

          <div class="js-timeline_item ag-timeline_item">
            <div class="ag-timeline-card_box">
              <div class="ag-timeline-card_meta-box">
                <div class="ag-timeline-card_meta">September 20th</div>
              </div>
              <div class="js-timeline-card_point-box ag-timeline-card_point-box">
                <div class="ag-timeline-card_point-white">
                  <img src="https://static.igem.wiki/teams/4905/wiki/hp/hp/public.svg" style="width:60%; margin-top:-20%; margin-left: auto;" alt="stakeholder"/>
                </div>
              </div>
            </div>
            <div class="ag-timeline-card_item">
              <div class="ag-timeline-card_inner">
                <div class="ag-timeline-card_info">
                  <div class="ag-timeline-card_desc">
                    <div class="row">
                      <div class="col-lg-5 col-xs-12"></div>
                      <div class="col-lg-7 col-xs-12">
                        <h2>September 20th</h2>
                        <p>Patient 2</p>
                      </div>
                    </div> 
                    <div class="row">
                      <div class="col-lg-12 col-xs-12">                   
                    <p align="justify">The patient told us about the negative impact of IBD on her life, since several treatments did not work or lost effectiveness over time. When comparing medications she used over the past years compared to cELPro, she saw potential in cELPro as a new treatment since it responds to the deficiencies of current treatments.   </p>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
              <div class="ag-timeline-card_arrow"></div>
            </div>
          </div>

          <div class="js-timeline_item ag-timeline_item">
            <div class="ag-timeline-card_box">
              <div class="js-timeline-card_point-box ag-timeline-card_point-box">
                <div class="ag-timeline-card_point-pink">
                  <img src="https://static.igem.wiki/teams/4905/wiki/hp/hp/businesss.svg" style="width:60%; margin-top:-20%; margin-left: auto;" alt="stakeholder"/>
                </div>
              </div>
              <div class="ag-timeline-card_meta-box">
                <div class="ag-timeline-card_meta">All year long</div>
              </div>
            </div>
            <div class="ag-timeline-card_item">
              <div class="ag-timeline-card_inner">
                <div class="ag-timeline-card_info">
                  <div class="ag-timeline-card_desc">
                    <div class="row">
                      <div class="col-lg-7 col-xs-12">
                        <h2>All year long</h2>
                        <p>Bart van Grevenhof</p>
                        <p>The gate/ Eindhoven University of Technology </p>
                        <p>Business Developer Student Entrepreneurship </p>
                      </div>
                      <div class="col-lg-5 col-xs-12">
                        <div class="ag-timeline-card_img-box">
                          <img src="https://static.igem.wiki/teams/4905/wiki/timeline/bart-foto.svg" style="width:80%;"class="ag-timeline-card_img" alt="Meeting 1"/>
                        </div>
                      </div>
                    </div> 
                    <div class="row">
                      <div class="col-lg-12 col-xs-12">                   
                    <p align="justify">Bart helped us multiple times during our project to advise us on making the best possible sales pitch. Moreover, he helped us develop a solid business plan.     </p>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
              <div class="ag-timeline-card_arrow"></div>
            </div>
          </div>

          <!-- Reflection -->
          <div class="js-timeline_item ag-timeline_item">
            <div class="ag-timeline-card_box">
              <div class="ag-timeline-card_meta-box">
                <div class="ag-timeline-card_meta">Reflection</div>
              </div>
              <div class="js-timeline-card_point-box ag-timeline-card_point-box">
                <div class="ag-timeline-card_point-black">
                  <img src="https://static.igem.wiki/teams/4905/wiki/hp/hp/reflection.svg" style="width:60%; margin-top:-20%; margin-left: auto;" alt="stakeholder"/>
                </div>
              </div>
            </div>
            <div class="ag-timeline-card_item">
              <div class="ag-timeline-card_inner">
                <div class="ag-timeline-card_info">
                  <div class="ag-timeline-card_desc">
                    <div class="readmorehp" style="background-color:#000000" id="hp54">Click to read reflection 5</div>
                  </div>
                </div>
              </div>
              <div class="ag-timeline-card_arrow"></div>
            </div>
          </div>

        </div>
      </div>
    </div>
  </section>
</div>


 <!--javascript for timeline-->
<script src="{{ url_for('static', filename = '../../../../static/js/human-practices.js')}}"></script>

<script src="//ajax.googleapis.com/ajax/libs/jquery/1.11.0/jquery.min.js"></script>
<script>

  (function ($) {
  $(function () {


    $(window).on('scroll', function () {
      fnOnScroll();
    });

    $(window).on('resize', function () {
      fnOnResize();
    });


    var agTimeline = $('.js-timeline'),
      agTimelineLine = $('.js-timeline_line'),
      agTimelineLineProgress = $('.js-timeline_line-progress'),
      agTimelinePoint = $('.js-timeline-card_point-box'),
      agTimelineItem = $('.js-timeline_item'),
      agOuterHeight = $(window).outerHeight(),
      agHeight = $(window).height(),
      f = -1,
      agFlag = false;

    function fnOnScroll() {
      agPosY = $(window).scrollTop();

      fnUpdateFrame();
    }

    function fnOnResize() {
      agPosY = $(window).scrollTop();
      agHeight = $(window).height();

      fnUpdateFrame();
    }

    function fnUpdateWindow() {
      agFlag = false;

      agTimelineLine.css({
        top: agTimelineItem.first().find(agTimelinePoint).offset().top - agTimelineItem.first().offset().top,
        bottom: agTimeline.offset().top + agTimeline.outerHeight() - agTimelineItem.last().find(agTimelinePoint).offset().top
      });

      f !== agPosY && (f = agPosY, agHeight, fnUpdateProgress());
    }

    function fnUpdateProgress() {
      var agTop = agTimelineItem.last().find(agTimelinePoint).offset().top;

      i = agTop + agPosY - $(window).scrollTop();
      a = agTimelineLineProgress.offset().top + agPosY - $(window).scrollTop();
      n = agPosY - a + agOuterHeight / 2;
      i <= agPosY + agOuterHeight / 2 && (n = i - a);
      agTimelineLineProgress.css({height: n + "px"});

      agTimelineItem.each(function () {
        var agTop = $(this).find(agTimelinePoint).offset().top;

        (agTop + agPosY - $(window).scrollTop()) < agPosY + .5 * agOuterHeight ? $(this).addClass('js-ag-active') : $(this).removeClass('js-ag-active');
      })
    }

    function fnUpdateFrame() {
      agFlag || requestAnimationFrame(fnUpdateWindow);
      agFlag = true;
    }


  });
})(jQuery);

</script>
            </div>
          </div>
        </div>
      </div>
    </body>

</html>

{% endblock %}